Enhabit, Inc. (NYSE:EHAB) Shares Sold by State Street Corp

State Street Corp trimmed its holdings in Enhabit, Inc. (NYSE:EHAB) by 38.9% in the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 1,161,697 shares of the company’s stock after selling 740,645 shares during the period. State Street Corp owned approximately 2.31% of Enhabit worth $9,177,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Bank of New York Mellon Corp grew its stake in Enhabit by 1.5% during the 2nd quarter. Bank of New York Mellon Corp now owns 400,575 shares of the company’s stock worth $3,573,000 after purchasing an additional 5,936 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its stake in Enhabit by 1,119.6% in the second quarter. Allspring Global Investments Holdings LLC now owns 45,832 shares of the company’s stock valued at $409,000 after buying an additional 42,074 shares during the last quarter. Paradice Investment Management LLC boosted its holdings in shares of Enhabit by 0.7% in the second quarter. Paradice Investment Management LLC now owns 1,525,037 shares of the company’s stock valued at $13,603,000 after acquiring an additional 11,128 shares during the period. Los Angeles Capital Management LLC purchased a new position in shares of Enhabit during the second quarter worth approximately $220,000. Finally, Quest Partners LLC acquired a new position in shares of Enhabit in the 2nd quarter valued at $177,000.

Enhabit Price Performance

Shares of NYSE:EHAB opened at $7.73 on Friday. The company has a quick ratio of 1.46, a current ratio of 1.46 and a debt-to-equity ratio of 0.85. The firm has a 50-day simple moving average of $7.67 and a 200 day simple moving average of $8.24. Enhabit, Inc. has a fifty-two week low of $6.85 and a fifty-two week high of $11.74. The company has a market cap of $388.70 million, a PE ratio of -3.33 and a beta of 1.89.

Enhabit (NYSE:EHAB) last posted its earnings results on Wednesday, November 6th. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.01). Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. The firm had revenue of $253.60 million for the quarter, compared to analyst estimates of $261.69 million. During the same period in the previous year, the firm earned $0.03 earnings per share. On average, sell-side analysts anticipate that Enhabit, Inc. will post 0.22 EPS for the current year.

Insider Transactions at Enhabit

In related news, Director Stuart M. Mcguigan purchased 15,000 shares of Enhabit stock in a transaction on Tuesday, December 10th. The stock was bought at an average price of $8.81 per share, with a total value of $132,150.00. Following the completion of the transaction, the director now directly owns 46,810 shares of the company’s stock, valued at approximately $412,396.10. This represents a 47.15 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Jeffrey Bolton acquired 4,000 shares of Enhabit stock in a transaction dated Thursday, December 12th. The stock was purchased at an average price of $8.69 per share, with a total value of $34,760.00. Following the completion of the purchase, the director now directly owns 98,144 shares of the company’s stock, valued at $852,871.36. The trade was a 4.25 % increase in their position. The disclosure for this purchase can be found here. 1.90% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on EHAB shares. Leerink Partners restated a “market perform” rating and issued a $8.00 price objective (down previously from $8.50) on shares of Enhabit in a research report on Tuesday, November 19th. Jefferies Financial Group upgraded Enhabit from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $8.25 to $9.50 in a research report on Monday, December 9th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $8.75.

Enhabit Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.